PORTFOLIO
Early-Stage Advantage
Via our prior early-stage funds and as individual angels and strategic investors, the Neovate team has invested more than $150 million, enabling dozens of tech and life sciences startups to reach key milestones, from clinical validation and commercial launch to strategic partnership and exit. Some of the representative investments are listed below.
Investments made by Mountain State Capital led by Matt Harbaugh, Mike Green, Nick Pachuda
Investments made by Kevin Rocco (Angel)
Investments made by Johnson & Johnson led by Nick Pachuda
Let’s Chat
If your life sciences innovation fits our investment criteria and you're seeking Seed-stage to Series A funding, we'd like to hear from you.